Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Markets & Finance

Jefferies Upgrades Rite Aid to 'Buy'


Jefferies upgraded Rite Aid (RAD) to buy from hold.

Analyst John Dahl says Rite Aid has done a laudable job moving the needle on the front-end side of its business. He says monthly comparable-store sales growth in the front-end has recently moved up into 5% to 7% region, vs. low-single-digit comparisons experienced earlier this year.

Dahl says improvements in the drugstore chain's execution and merchandise mix should continue to spur solid performance. He believes it's only a matter of time before Rite Aid demonstrates tangible improvements to the pharmacy side of its business, which should add upside for the company.

Dahl sees 8 cents fiscal 2004 (Feb.) earnings per share, and 22 cents in fiscal 2005. He has a $7.50 target.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus